Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

"We are pleased to report that all eight cohorts of our phase I first-in-human study of PRX-115, our recombinant uricase candidate being developed for the treatment of uncontrolled gout, are now ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

While gout is commonly linked to excessive drinking or poor diet, new research has revealed that genetics may play a larger ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of four abstracts that ...

Scientists from the University of California San Diego have uncovered a new cause of gout that could lead to more effective ...

Gout has often been seen as a consequence of lifestyle choices, but new research is rewriting this narrative. An ...

Get the facts on cost and allopurinol, how generics compare with brand names, what financial assistance may be available, and ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...